MedTrace Logo

Polarization Sensitive Retinal Tomography for Glaucoma Diagnosis

NCT01222065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2012-03-27

No results posted yet for this study

Summary

The proposed human clinical studies have three main objectives:

1. To determine reproducibility of peripapillary birefringence maps and identify features that measure the health of the RNFL.
2. To determine the normal variation in the birefringence maps with age.
3. To develop and test a classifier for glaucoma based on the birefringence maps using a case-control clinical trial.

This study is a case-control study intended to optimize feature selection for a future multi-center blinded study. The proposed clinical study does not measure conversion from normal to glaucoma.

Conditions

Sponsors & Collaborators

  • National Eye Institute (NEI)

    collaborator NIH

  • Courtney Frazier Swaney

    lead OTHER

Principal Investigators

  • Henry G Rylander, MD · University of Texas at Austin

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2010-12-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01222065 on ClinicalTrials.gov